Clinical Trial of Diagnostic Tests and Clinical Algorithms for Dengue in Febrile Subjects in Endemic Areas in Colombia

NCT ID: NCT04063774

Last Updated: 2019-08-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

1045 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-12-27

Study Completion Date

2018-07-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The present study aimed to develop a sensitive dengue diagnostic clinical algorithm using the resources that are available at the health care institutions, clinical expertise, and identification of signs and symptoms and variables of the hemogram associated with dengue. The performance of the potential algorithms were assessed under routine care. A single group cuasiexperimental study with a Bayesian adaptive design was conducted. Prior and cumulative information was used during intermediate analysis of clinical algorithms performance and according to these results algorithms were modified and then implemented in the subsequent study subjects. Men and women of all ages, seeking care due to fever of less than 15 days were recruited in 3 endemic areas in Colombia. The algorithms were applied by study physicians and blood samples taken for hemogram and dengue reference tests. It was planned that algorithms with high sensitivity (95%) and specificity (80%) were implemented in real life to assess their impact on patients outcomes alone and in combination with dengue rapid diagnostic tests but this was not feasible as not algorithms achieved the targetted performance. The experience of physicians using the algorithm in a mobile device was going to be explored with qualitative methods but this was explored with study physicians.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dengue

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Algorithms were developed and validated in silico, those with the highest sensitivity were tested in consecutive eligible subjects and their performance compared to dengue reference tests (gold standard combination of tests). Algorithms were modified according to intermediate analysis of performance planned in advance
Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Samples were coded and laboratory personnel were unaware of algorithm results, the participant did not know what algorithm prototype was tested.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Dengue diagnostic algorithm

single arm of consecutive enrolled subjects with fever in whom the dengue diagnostic algorithms were applied by study physician and blood sample taken for hemogram and dengue reference tests (gold standard)

Group Type EXPERIMENTAL

Dengue calculator

Intervention Type DIAGNOSTIC_TEST

Clinical diagnostic algorithms of dengue generated by discrete and continuos Bayes formulas installed in a mobile device

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dengue calculator

Clinical diagnostic algorithms of dengue generated by discrete and continuos Bayes formulas installed in a mobile device

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Fever of less than 15 days

Exclusion Criteria

* Origin of fever identified
Eligible Sex

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

COMFANDI CAJA DE COMPENSACION DEL VALLE DEL CAUCA

UNKNOWN

Sponsor Role collaborator

SISTEMA GENERAL DE REGALIAS CASANARE, SANTANDER VALLE DEL CAUCA

UNKNOWN

Sponsor Role collaborator

RED AEDES

UNKNOWN

Sponsor Role collaborator

Lyda Osorio

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Lyda Osorio

Professor

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lyda Osorio, MD PhD

Role: PRINCIPAL_INVESTIGATOR

Universidad del Valle

Diana Ma Caicedo, MD MSc

Role: PRINCIPAL_INVESTIGATOR

Universidad del Valle

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Regional de la OrinoquĂ­a

Yopal, Casanare Department, Colombia

Site Status

Clinica y Hospital Local de Piedecuesta

Piedecuesta, Santander Department, Colombia

Site Status

COMFANDI Torres y Alameda

Cali, Valle del Cauca Department, Colombia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Colombia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

144-016

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.